Different effects of l-arginine on the heat-induced unfolding and aggregation of proteins

Biologicals

Volumn 39, Issue 3, 2011, Pages 181-188

  Cirkovas, Andrejus ^a   Sereikaite, Jolanta ^a  

^a VILNIUS GEDIMINAS TECHNICAL UNIVERSITY   (Lithuania)

Author keywords

Aggregation; Growth hormones; Interferon 2b; L arginine; Thermal unfolding

Indexed keywords

ALPHA2B INTERFERON; ARGININE; GROWTH HORMONE;

ARTICLE; CIRCULAR DICHROISM; CONTROLLED STUDY; HEAT TREATMENT; HUMAN; MINK; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN STABILITY; PROTEIN TERTIARY STRUCTURE; PROTEIN UNFOLDING; SWINE; TURBIDITY;

ANIMALS; ARGININE; CIRCULAR DICHROISM; GROWTH HORMONE; HOT TEMPERATURE; HUMAN GROWTH HORMONE; HUMANS; INTERFERON ALFA-2B; MINK; NEPHELOMETRY AND TURBIDIMETRY; PROTEIN FOLDING; PROTEIN MULTIMERIZATION; PROTEIN STABILITY; PROTEIN STRUCTURE, TERTIARY; SWINE; UNFOLDED PROTEIN RESPONSE;

MUSTELA; SUS;

EID: 79957444331     PISSN: 10451056     EISSN: 10958320     Source Type: Journal    
DOI: 10.1016/j.biologicals.2011.04.003     Document Type: Article

References (40)

1. Lange C., Rudolph R. Suppression of protein aggregation by l-arginine. Curr Pharm Biotechnol 2009, 10:408-414.
2. Rudolph R. Renaturation of recombinant, disulfide-bonded proteins from "inclusion bodies" Modern methods in protein and nucleic acid analysis 1990, 149-171. Walter De Gruyter, Berlin, New York. H. Tschesche (Ed.).
3. Asano R., Kudo T., Makabe K., Tsumoto K., Kumagai I. Antitumor activity of interleukin-21 prepared by novel refolding procedure from inclusion bodies expressed in Escherichia coli. FEBS Lett 2002, 528:70-76.
4. Takahashi S., Ogasawara H., Watanabe T., Kumagai M., Inoue H., Hori K. Refolding and activation of human prorennin expressed in Escherichia coli: application of recombinant human rennin for inhibitor screening. Biosci Biotechnol Biochem 2006, 70:2913-2918.
5. Lechtken A., Zundorf I., Dingermann T., Firla B., Steinhilber D. Overexpression, refolding, and purification of polyhistidine-tagged human retinoic acid related orphan receptor RORalpha4. Protein Expr Purif 2006, 49:114-120.
6. Hsih M.H., Kuo J.C., Tsai H.J. Optimization of the solubilization and renaturation of fish growth hormone produced by Escherichia coli. Appl Microbiol Biotechnol 1997, 48:66-72.
7. Casaite V., Bruzyte S., Bukauskas V., Setkus A., Morozova-Roche L.A., Meskys R. Expression and purification of active recombinant equine lysozyme in Escherichia coli. Protein Eng Des Sel 2009, 22:649-654.
8. Arakawa T., Tsumoto K. The effects of arginine on refolding of aggregated proteins: not facilitate refolding, but suppress aggregation. Biochem Biophys Res Commun 2003, 304:148-152.
9. Arakawa T., Tsumoto K., Kita Y., Chang B., Ejima D. Biotechnology applications of amino acids in protein purification and formulations. Amino Acids 2007, 33:587-605.
10. Reddy K.R.C., Lilie H., Rudolph R., Lange C. l-arginine increases the solubility of unfolded species of hen egg white lysozyme. Protein Sci 2005, 14:929-935.
11. Maity H., Karkaria C., Davagnino J. Effects of pH and arginine on the solubility and stability of a therapeutic protein (fibroblast growth factor 20): relationship between solubility and stability. Curr Pharm Biotechnol 2009, 10:609-625.
12. Ejima D., Yumioka R., Arakawa T., Tsumoto K. Arginine as an effective additive in gel permeation chromatography. J Chromatogr A 2005, 1094:40-55.
13. Tsumoto K., Eijima D., Nagase K., Arakawa T. Arginine improves protein elution in hydrophobic interaction chromatography. J Chromatogr 2007, 1154:81-86.
14. Arakawa T., Tsumoto K., Nagase K., Ejima D. The effects of arginine on protein binding and elution in hydrophobic interaction and ion-exchange chromatography. Protein Expr Purif 2007, 54:110-116.
15. Ejima D., Yumioka R., Tsumoto K., Arakawa T. Effective elution of antibodies by arginine and arginine derivatives in affinity chromatography. Anal Biochem 2005, 345:250-257.
16. Arakawa T., Ejima D., Tsumoto K., Ishibashi M., Tokunaga M. Improved performance of column chromatography by arginine: dye-affinity chromatography. Protein Expr Purif 2007, 52:410-414.
17. Abe R., Kudou M., Tanaka Y., Arakawa T., Tsumoto K. Immobilized metal affinity chromatography in the presence of arginine. Biochem Biophys Res Commun 2009, 381:306-310.
18. Ishibashi M., Tsumoto K., Tokunaga M., Ejima D., Kita Y., Arakawa T. Is arginine a protein-denaturant?. Protein Expr Purif 2005, 42:1-6.
19. Srinivas V., Raman B., Rao K.S., Ramakrishna T., Rao Ch.M. Structural perturbation and enhancement of the chaperone-like activity of α-crystallin by arginine hydrochloride. Protein Sci 2003, 12:1262-1270.
20. Xie Q., Guo T., Lu J., Zhou H.M. The guanidine like effects of arginine on aminoacylase and salt-induced molten globule state. Int J Biochem Cell Biol 2004, 36:296-306.
21. Benjwal S., Verma S., Rohm K.H., Gursky O. Monitoring protein aggregation during thermal unfolding in circular dichroism experiments. Protein Sci 2006, 15:635-639.
22. Arakawa T., Kita Y., Ejima D., Tsumoto K., Fukada H. Aggregation suppression of proteins by arginine during thermal unfolding. Protein Pept Lett 2006, 13:921-927.
23. Baranauskaite L., Sereikaite J., Gedminiene G., Bumeliene Z., Bumelis V.A. Refolding of porcine growth hormone from inclusion bodies of Escherichia coli. Biocatal Biotransform 2005, 23:185-189.
24. Sereikaite J., Statkute A., Morkunas M., Radzevicius K., Borromeo V., Secchi C., et al. Production of recombinant mink growth hormone in E. coli. Appl Microbiol Biotechnol 2007, 74:316-323.
25. Bajorunaite E., Sereikaite J., Bumelis V.A. l-Arginine suppresses aggregation of recombinant growth hormones in refolding process from E. coli inclusion bodies. Protein J 2007, 26:547-555.
26. Gomez-Orellana I., Variano B., Miura-Fraboni J., Milstein S., Paton D.R. Thermodynamic characterization of an intermediate state of human growth hormone. Protein Sci 1998, 7:1352-1358.
27. Bloemendal M., Johnson W.C. Structural information on proteins from circular dichroism spectroscopy. Physical methods to characterize pharmaceutical proteins 1995, 65-100. Plenum Press, New York. J.N. Herron, W. Jiskoot, D.J.A. Crommelin (Eds.).
28. Cirkovas A, Sereikaite J. Probing of l-arginine as an additive for the temperature-induced aggregation of veterinary growth hormones: fluorescence study. Mol Biotechnol doi:10.1007/s12033-010-9370-6.
29. Philo J.S. A critical review of methods for size characterization of non-particulate protein aggregates. Curr Pharm Biotechnol 2009, 10:359-372.
30. Mahler H.C., Friess W., Grauschopf U., Kiese S. Protein aggregation: pathways, induction factors and analysis. J Pharm Sci 2009, 98:2909-2934.
31. Harada Y., Tatsumi H., Nakano E., Umezu M. Cloning and sequence analysis of mink growth hormone cDNA. Biochem Biophys Res Commun 1990, 173:1200-1204.
32. Parkinson E.J., Morris M.B., Bastiras S. Acid denaturation of recombinant porcine growth hormone: formation and self-association of folding intermediates. Biochemistry 2000, 39:12345-12354.
33. Beattie J. Structural and functional aspects of the interaction between growth hormone and its receptor. Biochim Biophys Acta 1993, 1203:1-10.
34. Spolaore B., Polverino de Laureto P., Zambonin M., Fontana A. Limited proteolysis of human growth hormone at low pH: isolation, characterization, and complementation of the two biologically relevant fragments 1-44 and 45-191. Biochemistry 2004, 43:6576-6586.
35. Schneider C.P., Trout B.L. Investigation of cosolute-protein preferential interaction coefficients; new insight into the mechanism by which arginine inhibits aggregation. J Phys Chem B 2009, 113:2050-2058.
36. Ghosh R., Sharma S., Chattopadhyay K. Effect of arginine on protein aggregation studied by fluorescence correlation spectroscopy and other biophysical methods. Biochemistry 2009, 48:1135-1143.
37. Arakawa T., Ejima D., Tsumoto K., Obeyama N., Tanaka Y., Kita Y., et al. Suppression of protein interaction by arginine: a proposed mechanism of the arginine effects. Biophys Chem 2007, 127:1-8.
38. Nudelman I., Akabayov S.R., Schnur E., Biron Z., Levy R., Xu Y., et al. Intermolecular interactions in a 44 kDa interferon-receptor complex detected by asymmetric reverse-protonation and two-dimensional NOESY. Biochemistry 2010, 49:5117-5133.
39. Hamada H., Takahashi R., Noguchi T., Shiraki K. Differences in the effects of solution additives on heat- and refolding-induced aggregation. Biotechnol Prog 2008, 24:436-443.
40. Lyutova E.M., Kasakov A.S., Gurvits B.Ya. Effects of arginine on kinetics of protein aggregation studied by dynamic laser light scattering and turbidimetry techniques. Biotechnol Prog 2007, 23:1380-1387.